ArticleTherapeutic advances in medical oncology2025

Prognostic significance of HER2-low and HER2-zero status before and after neoadjuvant chemotherapy in patients with HER2-negative breast cancer.

Youzhao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.